Search research articles
Contact Us
Filters
Showing results (111-120 of 124) with videos related to
Page
of 13
Sort By:
Cancer Research
|
February 11, 2012
Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients
Sari Pesonen, Iulia Diaconu, Lotta Kangasniemi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2023
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen, et al.
Cancer Immunology, Immunotherapy : CII
|
June 4, 2025
Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic cancer models
Santeri A Pakola, Nea Ojala, Tatiana V Kudling, et al.
Cancer Gene Therapy
|
April 10, 2025
Single-cell profiling of peripheral blood mononuclear cells from patients treated with oncolytic adenovirus TILT-123 reveals baseline immune status as a predictor of therapy outcomes
Tatiana V Kudling, Dmitrii Bychkov, James H A Clubb, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 29, 2010
Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF
Anniina Koski, Lotta Kangasniemi, Sophie Escutenaire, et al.
Oncoimmunology
|
August 7, 2023
Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer
Tatiana V Kudling, James H A Clubb, Santeri Pakola, et al.
Oncoimmunology
|
April 10, 2026
<i>Alistipes</i> and <i>Eggerthella</i> shape the response to oncolytic adenovirus therapy in mice and humans through short-chain fatty acid metabolism
Mirte van der Heijden, James Hugo Armstrong Clubb, Pande Putu Erawijantari, et al.
Oncoimmunology
|
July 18, 2022
Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression
Tatiana V Kudling, James H A Clubb, Dafne C A Quixabeira, et al.
Cancer Research
|
May 21, 2010
Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients
Vincenzo Cerullo, Sari Pesonen, Iulia Diaconu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 7, 2024
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors
Elise Jirovec, Dafne C A Quixabeira, James H A Clubb, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 124) with videos related to
Sort By:
Page
of 13
Cancer Research
|
February 11, 2012
Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients
Sari Pesonen, Iulia Diaconu, Lotta Kangasniemi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2023
Functional Homologous Recombination Assay on FFPE Specimens of Advanced High-Grade Serous Ovarian Cancer Predicts Clinical Outcomes
Sanna Pikkusaari, Manuela Tumiati, Anni Virtanen, et al.
Cancer Immunology, Immunotherapy : CII
|
June 4, 2025
Oncolytic adenovirus encoding variant interleukin-2 combined with chemotherapy enables PD-L1 inhibition in pancreatic cancer models
Santeri A Pakola, Nea Ojala, Tatiana V Kudling, et al.
Cancer Gene Therapy
|
April 10, 2025
Single-cell profiling of peripheral blood mononuclear cells from patients treated with oncolytic adenovirus TILT-123 reveals baseline immune status as a predictor of therapy outcomes
Tatiana V Kudling, Dmitrii Bychkov, James H A Clubb, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 29, 2010
Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSF
Anniina Koski, Lotta Kangasniemi, Sophie Escutenaire, et al.
Oncoimmunology
|
August 7, 2023
Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer
Tatiana V Kudling, James H A Clubb, Santeri Pakola, et al.
Oncoimmunology
|
April 10, 2026
<i>Alistipes</i> and <i>Eggerthella</i> shape the response to oncolytic adenovirus therapy in mice and humans through short-chain fatty acid metabolism
Mirte van der Heijden, James Hugo Armstrong Clubb, Pande Putu Erawijantari, et al.
Oncoimmunology
|
July 18, 2022
Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression
Tatiana V Kudling, James H A Clubb, Dafne C A Quixabeira, et al.
Cancer Research
|
May 21, 2010
Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients
Vincenzo Cerullo, Sari Pesonen, Iulia Diaconu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 7, 2024
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors
Elise Jirovec, Dafne C A Quixabeira, James H A Clubb, et al.
Page
of 13